EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efficacy and Safety of Two Epidural Magnesium Sulfate Regimens for Post-Cesarean Analgesia: A Prospective, Randomized Controlled Trial

Joseph Alejandro Veraza Almeida, Francisco Antonio Tapia Parada

Bali Journal of Anesthesiology · 2026-07 · 10 (3) · 157-160

DOI: 10.4103/bjoa.bjoa_21_26 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background: Optimal post-cesarean analgesia is critical for recovery. Magnesium sulfate (MgSO 4 ) is a known neuraxial adjuvant acting as an N-methyl-D-aspartate antagonist, yet the ideal dose balancing efficacy and neonatal safety remains undefined. This trial evaluated two low-dose epidural magnesium regimens. Materials and Methods: A prospective, double-blind, randomized controlled trial was conducted with 340 American Society of Anesthesiologists I–II parturients undergoing elective cesarean section. Patients received lidocaine 2% (300 mg) plus fentanyl (100 µg), supplemented with either 75 mg (Group SM75) or 100 mg (Group SM100) of MgSO 4 . Primary outcomes included pain intensity (visual analog scale [VAS] scores) at 2, 4, 8, 12, and 24 h. Secondary outcomes assessed rescue analgesia, block regression, and neonatal well-being (Apgar/resuscitation needs). Results: The SM75 group showed significantly lower pain scores at 2, 12, and 24 h compared to SM100 ( P < 0.05). At 24 h, 47.1% of the SM75 group reported zero pain (VAS 0), a result not achieved in the SM100 group ( P = 0.003). While rescue analgesia was similar, the SM100 group had a higher incidence of transient neonatal depression, though 5-min Apgar scores were comparable. Conclusion: Epidural MgSO 4 at 75 mg provides superior sustained analgesia and a better neonatal safety profile compared to 100 mg of MgSO 4 . Lower neuraxial doses appear to optimize the therapeutic index in obstetric anesthesia.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →